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Edited by Richard CogdellAbstract The properties of coenzymes Q (CoQ9 and CoQ10)
are closely linked to their redox state (CoQox/total CoQ) · 100.
In this work, CoQ redox state was biologically validated by high
performance liquid chromatography-electrochemical measure-
ment after modulation of mitochondrial electron ﬂow of cultured
cells by molecules increasing (rotenone, carbonyl cyanide chlo-
rophenylhydrazone) or decreasing (antimycin) CoQ oxidation.
The tissue speciﬁcity of CoQ redox state and content were
investigated in control and hypoxic rats. In control rats, there
was a strong negative linear regression between tissular CoQ
redox state and CoQ content. Hypoxia increased CoQ9 redox
state and decreased CoQ9 content in a negative linear relation-
ship in the diﬀerent tissues, except the heart and lung. This result
demonstrates that, under conditions of mitochondrial impair-
ment, CoQ redox control is tissue-speciﬁc.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Hypoxia; Rat1. Introduction
Coenzyme Qs (CoQs) are strongly implicated in the oxido-
reduction cellular metabolism. The length of the constitutive
isoprenoid side chain determines the homologous forms of
CoQs. CoQ10 is the major form in human cells and plants,
whereas CoQ9 predominates in rodents [1].
First, CoQs are the only non-protein components of the
respiratory chain. They are bound to mitochondrial mem-
brane proteins [2] and function as an obligatory electron
carrier between complexes I or II and complex III of the* Corresponding author. Fax: +33-(0)-5-62-17-09-05.
E-mail address: casteil@toulouse.inserm.fr (L. Casteilla).
Abbreviations: CoQs, coenzymes Q; CoQ9, coenzyme Q9; CoQ10,
coenzyme Q10; CoQred, reduced CoQ; CoQox, oxidized CoQ; HPLC,
high performance liquid chromatography; EC, electrochemical; CCCP,
carbonyl cyanide chlorophenylhydrazone; PBS, phosphate buﬀer
saline
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doi:10.1016/j.febslet.2004.10.067mitochondrial respiratory chain. At this site, partial oxida-
tion of CoQred produces a semi-reduced form, which inter-
acts with oxygen to generate superoxide anion. This accounts
for the major part of superoxide anion physiologically gen-
erated by the mitochondria. Second, in their CoQox, CoQs
behave as an obligatory cofactor of uncoupling protein ac-
tivity [3]. Last, CoQs are the only lipophilic antioxidants
which are biosynthesized in humans. In their reduced form
they have an antioxidant activity, as scavengers of reactive
oxygen species or lipid radicals and regenerators of a-to-
copherol from the a-tocopheroxyl radical [4]. Moreover,
CoQ redox state may be an useful marker of oxidative stress
[5,6].
Various studies have reported beneﬁcial eﬀects of CoQ10
supplementation in diﬀerent disease conditions during animal
experimentation [7,8] or human therapy [9,10]. As described
above, these lipophilic and ubiquitous molecules have func-
tions related to their redox state. To investigate CoQ content
and redox state, a sensitive and reliable method of quantifying
oxidized and reduced forms is required.
Several high performance liquid chromatography (HPLC)
methods have been described for the determination of total
CoQ10 [11–16]. CoQ10ox and CoQ10red have also been
measured using complex analytical procedures [12,16,17]. At
the present time, EC detection is the most sensitive of the
diﬀerent modes of detection coupled with HPLC. Recently,
Tang et al. [6,18] developed a simple and rapid HPLC-elec-
trochemical (EC) method for the determination of CoQsox
and CoQsred.
The aim of this work was to (i) biologically validate HPLC-
EC measurement of CoQ redox state by using molecules which
can modify mitochondrial CoQ oxidation and (ii) investigate
the tissular speciﬁcity of CoQ redox state and content in
control and hypoxic rats. Hypoxia is in fact well known to be
responsible for mitochondrial oxidative stress [19], which
could modify CoQ redox state.2. Materials and methods
2.1. Materials
CoQ9ox, CoQ10ox and other chemicals were obtained from Sigma
(L’Isle d’Abeau Chesnes, France). All chemicals were of HPLC grade.ation of European Biochemical Societies.
54 A. Galinier et al. / FEBS Letters 578 (2004) 53–572.2. Cell culture conditions for biological validation of CoQ redox state
Murine 3T3-F442A preadipocytes were routinely cultured as previ-
ously described [20]. Cells were seeded at a density of 4500 cells/cm2 in
Dulbecco’s modiﬁed Eagle’s medium supplemented with 10% fetal calf
serum. Measurements were performed at a pre-conﬂuent state. Mole-
cules acting at diﬀerent levels of the mitochondrial respiratory chain
were chosen to increase or decrease CoQ oxidation. Rotenone, an
inhibitor of complex I, and carbonyl cyanide chlorophenylhydrazone
(CCCP), an uncoupler, increase CoQ oxidation. On the contrary, an-
timycin, an inhibitor of complex III, decreases CoQ oxidation. Mole-
cules were dissolved in ethanol to a ﬁnal concentration of 0.4% in the
medium. Controls were performed with 0.4% ethanol. These molecules
were used at concentrations which only moderately aﬀect cell respi-
ration: rotenone (109 M) and antimycin (2 · 108 M) which inhibit
cell respiration by 15%, and CCCP (106 M) which increases it by 15%
were added to the medium. At diﬀerent times, cells were washed twice
with phosphate buﬀer saline (PBS), trypsinized and collected in PBS.
After centrifugation (400 g,10 min), the pellet was homogenized in
100 ll of PBS and stored at )80 C. This freezing procedure was
validated by comparison with measurement of freshly prepared
homogenates.Fig. 1. Typical HPLC-EC chromatogram of CoQ9 and CoQ10. (A)
Calibrators at the following concentrations: 1545 nM for CoQ9red (1),
1576 nM for CoQ10red (2), 1180 nM for CoQ9ox (3) and 1113 nM for
CoQ10ox (4). (B) Cell homogenate after 2-propanol extraction.2.3. Animals and treatments
Male Wistar rats (220–260 g) were fed ad libitum. In a ﬁrst experi-
ment, 6 rats were killed by exsanguination. The dissected organs were
immediately frozen in liquid nitrogen and stored at )80 C until
analysis. In a second experiment, three rats were exposed to hypoxia in
a hypobaric chamber simulating 8000 m above sea level (270 mmHg,
21% O2) for 4 h (acute hypoxia) and three control rats breathed am-
bient air. After exsanguination, dissected organs were treated as de-
scribed above.
2.4. Quantiﬁcation of CoQs (reduced and oxidized forms)
Extraction of biological samples. In order to deﬁne the best extrac-
tion conditions for preventing CoQ oxidation, two comparative assays
were performed with 3T3-F442A cells (minimum 250 000 cells). In the
ﬁrst assay, 100 ll of cell homogenate was mixed with 500 ll of ethanol
and centrifuged (4000 g, 3 min). The supernatant was extracted with
2 ml of hexane. After evaporation of the hexane phase, the pellet was
dissolved in 500 ll of the chromatographic mobile phase (see HPLC-
EC apparatus below). In the second assay, 100 ll of cell homogenate
was mixed with 500 ll of 2-propanol, centrifuged (4000 g, 3 min) and
the supernatant was recovered. 50 ll of mobile phase (ﬁrst assay) or of
the 2-propanol extract (second assay) was injected into the HPLC
system.
In addition, to evaluate CoQ content recovery and CoQred con-
servation during 2-propanol extraction, measurements were done with
cellular homogenates with or without a known quantity of CoQred
standard (107 nmol).
For the subsequent experiments, 2-propanol extraction was used.
Cell homogenates were extracted as described above. Frozen tissues
(100 mg) were added to 0.9 ml of 2-propanol and homogenized with an
Ultraturax blender. 100 ll of this homogenate was mixed with 500 ll
of 2-propanol and treated as described above.
HPLC-EC apparatus. This consisted of a Gilson 307 pump, a
Rheodine injector, an analytical column and an ESA Coulochem 2
Electrochemical Detector (Model 5200 A) with a Pentium II computer/
controller with EuroChrom 2000 Integration Package for Windows.
Brieﬂy, a guard cell (ESA Model 5020) (E1) was placed between the
pump and the injector to oxidize electroactive materials in the mobile
phase. The analytical cell (ESAModel 5010-porous graphite) consisted
of a series of two coulometric electrodes and was connected in series to
the analytical column: the ﬁrst electrode (E2) was for CoQ reduction
and the second electrode (E3) was for CoQred detection. The diﬀerent
homologs, CoQ9 and CoQ10, were identiﬁed by chromatographic
separation. In-preﬁlters were placed between the pump and the guard
cell and between the analytical column and the analytical cell. The
analytical column was a reverse-phase Hypersil BDS C18 column (4
mm 25 cm, 5 lm beads). The mobile phase for isocratic elution of
CoQ9 and CoQ10 contained sodium acetate (3.4 g), 8 mL of acetic
acid, 8 mL of 2-propanol, 344 mL of methanol and 80 mL of hexane.
The ﬂow rate of the mobile phase (degassed before use) was 1 mL/min.
The HPLC-EC system was set at room temperature (21 1 C).
Preparation of calibrators. Oxidized and reduced forms of CoQs
were identiﬁed and quantiﬁed using self-made external calibrators. Inan amber balloon, 2 mg of CoQox (Q9 or Q10) was dissolved in 100
mL of 2-propanol. Concentrations of these stock solutions were con-
ﬁrmed by measuring absorbance at 275 nm and by reference to known
extinction coeﬃcients (E1%1cm185 for CoQ9 and 165 for CoQ10). Five ml
of the CoQox stock solutions was diluted in the mobile phase (v/v),
aliquoted and frozen at )80 C. The rest (95 ml) of each stock solution
was reduced in a loop to )1000 mV in the system pump-guard cell
maintained in the dark for approximately 3 h. The conversion rate of
CoQox to CoQred was around 99%. After 6 months at )80 C, a loss
of only 2% of CoQred was observed in the reduced stock solutions.
Coulometric detection. To optimize the applied EC potentials in our
HPLC conditions, a hydrodynamic voltamogram was obtained by
repeated injections for all compounds studied. On the basis of the
assessed hydrodynamic voltamogram, and to oxidize any electro-
chemically active eluate, the guard cell potential was always set at
+1000 mV. The E2 and E3 cell potentials were set at )650 and +420
mV, respectively. EC detection in the analytical cell was carried out
after speciﬁc reduction of CoQox by E2. Oxidation by E3 then enabled
electron ﬂow to be detected.
2.5. CoQ redox state
This was calculated for CoQ9 and CoQ10 as: ([CoQox]/[total
CoQ]) 100 with [CoQox] + [CoQred]¼ [total CoQ].
2.6. Statistical analysis
Means S.E.M. were calculated and statistically signiﬁcant diﬀer-
ences between two groups were determined by Student’s t test at
P < 0:05.
2.7. External analytical quality control
Since 2003, the results of this technique are compared with the an-
alytical quality program organized by the National Institute of Stan-
dard Technology (NIST) (Gaithersburg, USA) on lyophilized serums.
The results are in complete agreement with the median of a four lab-
oratories interassay.3. Results and discussion
3.1. Analytical conditions
Calibration, reproducibility and sensitivity of chromato-
graphic analysis. CoQ calibrator solution (mixture of the four
diluted stock solutions) was prepared in 2-propanol (or in
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A. Galinier et al. / FEBS Letters 578 (2004) 53–57 55ethanol/hexane) as for biological samples. Fig. 1A shows a
typical chromatogram. The two forms of each CoQ were well
separated from one another. Analysis was fast, with retention
times of 6.0, 7.5, 9.0, and 13.5 min, respectively, for
CoQ9red, CoQ10red, CoQ9ox, and CoQ10ox. For the 4
forms, calibration curves were performed with three diﬀerent
calibrator solutions. An excellent linear relationship
(r2¼+0.99) was observed between the area of the peak (mV/
min) and the molar concentration ratio of each compound
over a wide concentration range (from 10 to 3000 nM).
Variation coeﬃcients were 2.9, 3.5, 3.5 and 3.7% for
CoQ9red, CoQ10red, CoQ9ox and CoQ10ox, respectively.
The limits of detection were 21 pmol for CoQsred and 15
pmol for CoQsox.
Extraction of biological samples. The two extraction condi-
tions were used for quantiﬁcation of either total CoQ9 or
CoQ10 [2,6,21,22]. However, it was observed that ethanol/
hexane extraction converted the CoQs to the oxidized form
[23].
Fig. 1B shows a typical chromatogram obtained with 2-
propanol extraction. Total CoQ9 (ox and red) recovery was
41.9 4.2 pmol/106 cells and was not signiﬁcantly diﬀerent
from that obtained with ethanol/hexane extraction (38.6 3.5)
(results not shown). However, there was more CoQ9red (and
less CoQ9ox) with 2-propanol extract than with ethanol/hex-
ane extract (results not shown). In this way, the values of redox
state were 78% with ethanol/hexane and 55% with 2-propanol.A
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Fig. 2. CoQ9 redox state after modulation of the mitochondrial re-
spiratory chain electron ﬂow of cultured cells. (A) Cells were treated 60
min with antimycin (An, 2 108 M), rotenone (R, 109 M), CCCP
(106 M) or 0.4% ethanol (control, C). (B) Cells were treated between 1
and 60 min with An 2 108 M ðjÞ, R 109M ðmÞ or 0.4% ethanol
(control, }). These concentrations of An and R inhibit cell respiration
by 15% and the concentration of CCCP increases it by 15%. Results
are expressed as (A) meansS.E.M. (four independent experiments)
or (B) means (two independent experiments). **P < 0:01 and
***P < 0:001 versus (C).These results show that, compared with ethanol/hexane ex-
traction, 2-propanol extraction protects CoQ from oxidation.
Moreover, when 107 nmol of CoQ9red standard were added
to a cell homogenate and extracted with 2-propanol, total
CoQ9 and CoQ9red recoveries were 98 2% and 96 1%,
respectively (results not shown).
Thus, 2-propanol extraction reliably measured CoQ content
or CoQ redox state for biological samples and was used for the
subsequent experiments.
3.2. Biological validation of CoQ redox state by modulation of
mitochondrial electron ﬂow
The measurements of CoQ redox state were biologically
validated using various molecules well known to modify elec-
tron ﬂow at diﬀerent levels of the respiratory chain. Thus,CoQ10 redox state (%)
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Fig. 3. Linear regression between CoQ redox state, CoQ content or
between CoQ9 content and CoQ9 redox state in tissues* of control
rats. (A) CoQ9 redox state as a function of CoQ10 redox state, (B)
CoQ10 content as a function of CoQ9 content and (C) CoQ9 redox
state as a function of CoQ9 content in lung ð}Þ, spleen ðnÞ, glycolytic
muscle ðrÞ, oxidative muscle ( – ), heart ðdÞ, kidney ðmÞ and liver ðjÞ.
*Testis ðÞ was not taken into consideration for the determination of
linear regression between CoQ9 redox state and CoQ9 content. Results
are expressed as meansS.E.M. for six rats.
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Fig. 4. Relationship between CoQ9 redox state and CoQ9 content in tissues of control rats ðrÞ and rats subjected to hypoxia ð}Þ (n¼ 3 in each
group).
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spectively, were chosen to inhibit mitochondrial electron ﬂow
and CCCP to increase it [24–26]. By inhibiting electron ﬂow at
the level of complex I, rotenone limits CoQ reduction and en-
hances CoQ oxidation. On the other hand, antimycin, by
blocking the electron ﬂow at the level of the Q-cycle, helps to
maintain CoQ reduction. CCCP, acting as a protonophore,
dissipates the transmembrane proton gradient, reduces the
constraints on the mitochondrial respiratory chain and en-
hances CoQ oxidation. Fig. 2A illustrates the eﬀects of these
molecules on CoQ9 redox state after one hour of incubation. As
expected, CoQ9 redox state was signiﬁcantly decreased in the
presence of antimycin and signiﬁcantly increased in the presence
of rotenone and CCCP. Similar results were obtained with
CoQ10 (results not shown). The kinetics of the CoQ redox
states were determined between 1 and 60 min after addition of
rotenone or antimycin. These molecules induced a marked
modiﬁcation of CoQ9 redox state within 1 min (Fig. 2B).
Similar results were obtained with CoQ10 (results not shown).
These results represent detection of the reduced and oxidized
forms as expected under the experimental conditions de-
scribed. They biologically validate the measurement of CoQs
redox states in complex biological matrixes despite sample
handling. It was noteworthy that a slight change in respiratory
chain activity rapidly inﬂuenced the whole cellular CoQ redox
state.3.3. Relationship between CoQ redox state and CoQ content in
rat control tissues
Fig. 3A shows a positive linear regression between CoQ9
redox state and CoQ10 redox state of diﬀerent tissues
(slope¼ 0.858). CoQ9 and CoQ10 redox states thus have ap-
proximatively the same value for a given tissue, but values vary
between diﬀerent tissues. On the whole, we obtained higher
proportions of reduced CoQ than authors who used a more
complex extraction method and HPLC-UV detection [27].
However, we observed proportions of oxidized CoQ9 similar to
those obtained recently in mouse tissues (lung, liver andmuscle)
[18]. Fig. 3B shows a positive linear regression between CoQ10
content and CoQ9 content. So, in each tissue, CoQ9 and CoQ10
contents vary in the same proportion. We observed that each
tissue is characterized not only by its redox state but also by its
CoQ9 content. For example, liver and lung (Fig. 3C) have the
highest and lowest CoQ9 contents but are characterized by a
low and a high redox state, respectively. Testis CoQ9 seems
protected from oxidation, perhaps by the presence of high levels
of other antioxidants, such as a-tocopherol as described in
spermatozoa [28]. Finally, we demonstrated for the diﬀerent
tissues (testis excluded) a negative linear regression between
CoQ9 redox state and CoQ9 content (Fig. 3C) and between
CoQ10 redox state and CoQ10 content (results not shown).
These results indicate that for most rat control tissues, CoQ
redox state is strongly linked to CoQ content, for both CoQ9
A. Galinier et al. / FEBS Letters 578 (2004) 53–57 57and CoQ10. It appears that, in physiological conditions, tis-
sular CoQ content determines the CoQ redox state (or recip-
rocally).3.4. CoQ redox state and CoQ content in tissues of rats
subjected to hypoxia
Hypoxia occurs in various conditions (vascular and pul-
monary diseases or cancer) [29] and is associated with mito-
chondrial oxidative stress [19] whose intensity varies according
to the tissue. After hypoxia, CoQ10 was modiﬁed only in the
heart. This tissue showed signiﬁcantly higher values of CoQ10
content and CoQ10 redox state than controls (results not
shown).
Fig. 4 shows the relationship between CoQ9 redox state and
CoQ9 content in diﬀerent tissues (liver, kidney, testis, heart
and lung) of rats under hypoxic or normoxic conditions.
Comparatively to control tissues, liver, kidney and testis of
rats under hypoxia showed higher values in CoQ9 redox state
(4.34 0.52% versus 14.90 0.62, P < 0:001; 11.48 3.25
versus 26.59 0.67, P < 0:05; 9.62 2.00 versus 18.45 0.10,
P < 0:05 respectively) and lower values in CoQ9 content
(402.08 52.84 nmol/g of tissue versus 138.97 2.24, P < 0:05;
236.38 23.06 versus 140.85 1.56, P < 0:05; 72.37 7.23
versus 28.90 3.23, P < 0:05). Moreover, there was a negative
linear regression between these two parameters. This increase
in CoQ9 redox state is consistent with the mitochondrial oxi-
dative stress described during hypoxia [19]. Comparatively to
controls, heart from rats under hypoxia showed high values in
CoQ9 redox state (20.69 5.60% versus 68.83 3.08,
P < 0:01) and similar values in CoQ9 content (207.03 23.56
nmol/g of tissue versus 222.77 13.83, ns). Comparatively to
controls, lung from hypoxic rats showed similar values in
CoQ9 redox state (37.92 4.83% versus 45.47 1.63, ns) and
lower values in CoQ9 content (15.07 2.74 nmol/g of tissue
versus 6.38 0.29, P < 0:05). However, no signiﬁcant linear
regression between CoQ9 redox state and CoQ9 content was
observed in heart and lung. This can be explained by diﬀerent
adaptive responses of tissues for these CoQ parameters during
low oxygen tension. Indeed, it is well known that some tissues
(lung, heart) are able to extract variable oxygen concentrations
and then adapt well to hypoxia [30]. Our results agree with a
previous study in which HIF-1a, a marker reciprocally regu-
lated by oxygen tension, was strongly detected in liver, kidney,
spleen and muscle of mice subjected to 6% hypoxia but was
present at a low level in the heart and absent in the lung [31].
In conclusion, this study suggests that evaluation of CoQ
content and redox state is necessary to improve our knowledge
of cellular CoQ regulation. Moreover, it emphasizes the tissue
speciﬁcity of CoQ redox control in pathological situations
associated with mitochondrial dysfunction.
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